Global Health Ventures, Inc. (OTC:GHLV) has announced the preliminary test results for its male sexual enhancement drug X-Excite. Test results for the drug manufactured by Vida Pharma proved to be satisfactory in the areas of color and taste. Several more samples of the drug will be produced to bring the drug’s hardness to an acceptable range.
Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.
Formerly Goldtown Investments Corp, Global Health Ventures is engaged in the acquisition and licensing of healthcare related technologies. It is a healthcare technology financial company. As of May 31, 2009, the company is also developing technology to administer drugs sublingually.
Follow us on Twitter: http://www.twitter.com/pennystockspro
Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
